Predict your next investment

Venture Capital
pallasiteventures.com

See what CB Insights has to offer

Investments

26

Portfolio Exits

3

About Pallasite Ventures

Pallasite Ventures provides seed and mezzanine financing for new projects within the real estate, technology, and media fields.

Pallasite Ventures Headquarters Location

Chicago, Illinois,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Pallasite Ventures News

Oncoustics Closes $5M+ Seed Funding

Jul 22, 2022

Oncoustics , a Toronto, Canada-based provider of ultrasound-based tissue characterization solutions, raised $5M+ in Seed funding. The round was led by Creative Ventures and Saltagen Ventures with participation from NorthSpring Capital Partners, Fraser Kearney Capital Corp., Pallasite Ventures, and Dr. Chen Fong, a renowned radiologist, entrepreneur/investor and inductee into the Order of Canada for his contributions to medical technology innovation and philanthropy. With this close, Oncoustics added Dr. Fong on behalf of Saltagen, and James Wang of Creative Ventures to its board of directors. The company intends to use the funds to advance its SaMD (software as a medical device) technology for the low-cost assessment of structural diseases at point of care. Led by CEO Beth Rogozinski, Oncoustics applies AI to raw ultrasound signals to do tissue characterization at point of care for low-cost, noninvasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Oncoustics’ first product, the OnX liver assessment solution, is focused on detecting structural liver diseases including fibrosis and steatosis (fat) that can occur in all types of chronic liver disease (CLD). The solutions for ultrasound will be submitted for regulatory approval in the United States (FDA 510(k)), Canada (Health Canada medical device license) and the European Union (CE Mark). The OnX Liver Assessment Solution has not been cleared for clinical use and is For Investigational Use Only. FinSMEs 22/07/2022

Pallasite Ventures Investments

26 Investments

Pallasite Ventures has made 26 investments. Their latest investment was in Oncoustics as part of their Seed VC on July 7, 2022.

CBI Logo

Pallasite Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/21/2022

Seed VC

Oncoustics

$4.3M

Yes

1

1/19/2022

Series A

Ionomr Innovations

$15M

No

6

8/25/2020

Series A

Prescryptive Health

$26M

Yes

1

1/9/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/17/2019

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/21/2022

1/19/2022

8/25/2020

1/9/2020

12/17/2019

Round

Seed VC

Series A

Series A

Series A

Seed VC

Company

Oncoustics

Ionomr Innovations

Prescryptive Health

Subscribe to see more

Subscribe to see more

Amount

$4.3M

$15M

$26M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

6

1

10

10

Pallasite Ventures Portfolio Exits

3 Portfolio Exits

Pallasite Ventures has 3 portfolio exits. Their latest portfolio exit was Popular Pays on March 23, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/23/2022

Acquired

$99M

1

1/9/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/10/2019

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/23/2022

1/9/2020

4/10/2019

Exit

Acquired

Acquired

Acq - Fin

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Pallasite Ventures Team

2 Team Members

Pallasite Ventures has 2 team members, including current Managing Partner, Christopher Bissonnette.

Name

Work History

Title

Status

Christopher Bissonnette

Managing Partner

Current

David Light

Founder

Former

Name

Christopher Bissonnette

David Light

Work History

Title

Managing Partner

Founder

Status

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.